You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Eisai Co., Ltd. v. Glenmark Pharmaceuticals Limited (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Eisai Co., Ltd. v. Glenmark Pharmaceuticals Limited
The small molecule drug covered by the patent cited in this case is ⤷  Sign Up .

Details for Eisai Co., Ltd. v. Glenmark Pharmaceuticals Limited (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2019-06-26 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (nmg) (Entered:…2019 26 August 2019 1:19-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.